Itama Ranoraya Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Itama Ranoraya Tbk trades at Rp368 (market cap 598.4B, 494.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Itama Ranoraya Tbk is far larger — about 3.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Itama Ranoraya Tbk is more actively traded (494.5K versus 96.7K). Which is the better fit depends on your goals.
| IRRA | OBAT | |
|---|---|---|
Market Cap | 598.4B | 167.37B |
Volume | 494.5K | 96.7K |
Lot | 4.95K | 967 |
Turnover | 183.16M | 23.82M |
Average Price | 370.4 | 246.34 |
Value | 183.16M | 23.82M |
Indicative Equilibrium Price | 368 | 248 |
Indicative Equilibrium Volume | 839 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Itama Ranoraya Tbk ( theEntity) was established for the first time based on Deed of Establishment of Limited Liability Entity dated November 30, 1989 Number 116, made before Esther Daniar Iskandar, S.H., Notary in Jakarta. PT Global Dinamika Kencana is the majority shareholder of the Entity and also the Ultimate Parent Entity. The entity has started commercial operations at July 22, 2002.
Read more on IRRA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →